Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Jennifer Kiser

Concepts (358)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antiviral Agents
32
2025
739
6.160
 Why?
Anti-HIV Agents
35
2025
775
4.490
 Why?
HIV Infections
56
2025
2828
4.290
 Why?
Adenine
29
2025
270
4.140
 Why?
Hepatitis C
13
2023
267
4.130
 Why?
Hepatitis C, Chronic
14
2025
164
3.930
 Why?
Ribavirin
15
2020
91
3.750
 Why?
Sofosbuvir
13
2025
62
3.680
 Why?
Drug Interactions
21
2019
407
3.270
 Why?
Tenofovir
30
2025
243
3.220
 Why?
Tandem Mass Spectrometry
17
2025
532
2.290
 Why?
Hepacivirus
11
2025
261
1.930
 Why?
Dried Blood Spot Testing
13
2024
104
1.880
 Why?
Proline
5
2019
79
1.850
 Why?
Organophosphates
15
2025
134
1.760
 Why?
Oligopeptides
8
2015
271
1.750
 Why?
Emtricitabine
19
2025
175
1.720
 Why?
Organophosphonates
12
2014
93
1.560
 Why?
Ritonavir
8
2021
74
1.440
 Why?
Protease Inhibitors
4
2020
107
1.390
 Why?
Coinfection
5
2024
137
1.290
 Why?
Chromatography, Liquid
14
2025
433
1.290
 Why?
Benzimidazoles
6
2025
170
1.220
 Why?
Phosphorous Acids
3
2019
13
1.190
 Why?
Fluorenes
4
2020
44
1.080
 Why?
Pyrophosphatases
3
2016
28
1.070
 Why?
Hepatitis B
4
2024
70
1.050
 Why?
Nucleotides
3
2016
125
1.050
 Why?
Anti-Retroviral Agents
5
2019
233
0.930
 Why?
Drug Therapy, Combination
12
2018
1062
0.860
 Why?
Pyridines
5
2015
506
0.820
 Why?
Polyphosphates
7
2022
37
0.770
 Why?
Erythrocytes
8
2016
699
0.760
 Why?
Humans
101
2025
136803
0.750
 Why?
Cell Phone
1
2022
75
0.750
 Why?
Reverse Transcriptase Inhibitors
5
2014
84
0.740
 Why?
HIV Protease Inhibitors
5
2011
69
0.740
 Why?
Viral Load
11
2024
464
0.720
 Why?
Membrane Transport Proteins
4
2016
162
0.710
 Why?
Simeprevir
2
2018
9
0.710
 Why?
HIV-1
7
2021
863
0.690
 Why?
Sulfonamides
5
2019
513
0.680
 Why?
Mobile Applications
1
2022
182
0.650
 Why?
Therapies, Investigational
1
2019
17
0.640
 Why?
Medication Adherence
12
2022
468
0.630
 Why?
Heterocyclic Compounds, 3-Ring
2
2023
32
0.620
 Why?
Respiratory Syncytial Virus Infections
1
2020
127
0.610
 Why?
Leukocytes, Mononuclear
9
2025
558
0.590
 Why?
Ethanol
1
2023
606
0.590
 Why?
Adult
45
2025
37643
0.580
 Why?
Male
55
2025
67330
0.570
 Why?
Antiretroviral Therapy, Highly Active
4
2015
271
0.570
 Why?
Pyridazines
2
2021
56
0.570
 Why?
Middle Aged
39
2025
33239
0.560
 Why?
Solid Phase Extraction
2
2014
25
0.550
 Why?
Lung Transplantation
1
2020
313
0.540
 Why?
Pyrimidinones
2
2008
113
0.530
 Why?
HIV Integrase Inhibitors
1
2018
70
0.530
 Why?
Inosine
1
2016
14
0.520
 Why?
Liver
2
2016
1940
0.520
 Why?
Guanosine
1
2016
41
0.510
 Why?
Pharmacogenomic Variants
1
2016
35
0.510
 Why?
Purines
1
2016
176
0.480
 Why?
Female
50
2025
72816
0.480
 Why?
Carbamates
2
2025
49
0.480
 Why?
Chromatography, High Pressure Liquid
2
2015
597
0.470
 Why?
Drug Discovery
1
2016
141
0.470
 Why?
Drug Monitoring
3
2022
218
0.470
 Why?
Isoniazid
2
2012
63
0.460
 Why?
Serum
1
2015
59
0.460
 Why?
Adenosine
1
2016
225
0.460
 Why?
Intracellular Space
1
2014
68
0.450
 Why?
Kidney
4
2016
1467
0.440
 Why?
Pre-Exposure Prophylaxis
5
2020
213
0.430
 Why?
HIV
4
2019
234
0.430
 Why?
Receptors, Adrenergic, alpha
1
2013
26
0.430
 Why?
Priapism
1
2013
11
0.430
 Why?
Adrenergic alpha-Antagonists
1
2013
34
0.420
 Why?
Telemedicine
1
2022
852
0.420
 Why?
Cytochrome P-450 CYP3A Inhibitors
1
2013
18
0.420
 Why?
Antitubercular Agents
2
2012
203
0.420
 Why?
Deoxycytidine
6
2017
179
0.420
 Why?
Hepatitis B, Chronic
3
2022
23
0.390
 Why?
Hepatitis B virus
4
2024
40
0.390
 Why?
Gastric Bypass
1
2014
119
0.380
 Why?
Treatment Outcome
13
2025
10748
0.380
 Why?
Alanine
5
2025
152
0.360
 Why?
Phenotype
2
2016
3189
0.350
 Why?
Prospective Studies
17
2022
7573
0.350
 Why?
HIV Seronegativity
1
2010
28
0.350
 Why?
Antacids
1
2010
16
0.350
 Why?
Pyrrolidinones
1
2010
28
0.340
 Why?
Genotype
6
2023
1914
0.340
 Why?
Pyrimidines
3
2021
470
0.340
 Why?
Patient Compliance
3
2017
577
0.330
 Why?
Tuberculosis
2
2012
279
0.330
 Why?
Pharmacy Service, Hospital
1
2011
90
0.320
 Why?
Blood Chemical Analysis
4
2019
99
0.320
 Why?
Plasma
4
2016
213
0.320
 Why?
Area Under Curve
4
2018
314
0.310
 Why?
Pregnancy Complications, Infectious
3
2025
390
0.310
 Why?
Reproducibility of Results
8
2016
3265
0.310
 Why?
Uridine Monophosphate
2
2019
15
0.310
 Why?
Drug Prescriptions
1
2011
244
0.300
 Why?
Fluorobenzenes
1
2008
16
0.290
 Why?
Young Adult
17
2025
13129
0.290
 Why?
Drug Stability
5
2016
167
0.280
 Why?
Adolescent
20
2020
21385
0.280
 Why?
Guidelines as Topic
1
2009
276
0.270
 Why?
Atazanavir Sulfate
5
2015
41
0.270
 Why?
Liver Transplantation
1
2014
871
0.260
 Why?
Sensitivity and Specificity
5
2014
1936
0.260
 Why?
Half-Life
3
2015
164
0.260
 Why?
Esomeprazole
1
2006
7
0.250
 Why?
Anti-Ulcer Agents
1
2006
16
0.250
 Why?
Glycerophospholipids
2
2023
34
0.250
 Why?
Pharmacology, Clinical
1
2006
9
0.250
 Why?
Sustained Virologic Response
3
2023
40
0.250
 Why?
Hepatocytes
3
2016
220
0.240
 Why?
Education
1
2006
107
0.240
 Why?
Heterocyclic Compounds, 4 or More Rings
1
2025
20
0.240
 Why?
Proton Pump Inhibitors
1
2006
109
0.230
 Why?
South Africa
4
2015
219
0.230
 Why?
Phosphates
3
2015
182
0.220
 Why?
Anemia
2
2016
170
0.220
 Why?
Biomarkers
5
2023
4145
0.210
 Why?
Variola virus
1
2022
2
0.200
 Why?
Smallpox
1
2022
8
0.200
 Why?
Health Personnel
1
2009
701
0.200
 Why?
World Health Organization
1
2022
123
0.190
 Why?
Delivery of Health Care
1
2009
935
0.190
 Why?
Linear Models
2
2014
846
0.180
 Why?
Cyclopropanes
2
2019
90
0.180
 Why?
Blood Platelets
1
2025
407
0.180
 Why?
Cross-Over Studies
4
2020
562
0.180
 Why?
Lopinavir
3
2020
30
0.180
 Why?
Dideoxynucleosides
2
2023
21
0.180
 Why?
Point-of-Care Systems
1
2023
163
0.180
 Why?
Phosphorylation
2
2015
1758
0.170
 Why?
Interferons
2
2019
202
0.170
 Why?
Aminoisobutyric Acids
1
2019
7
0.160
 Why?
Drug Administration Schedule
3
2019
785
0.160
 Why?
Lactams, Macrocyclic
1
2019
49
0.160
 Why?
Homosexuality, Male
2
2017
184
0.160
 Why?
Neutrophils
1
2025
1236
0.160
 Why?
Pyrrolidines
1
2019
80
0.160
 Why?
Quinoxalines
1
2019
66
0.160
 Why?
Leucine
1
2019
111
0.150
 Why?
Nucleic Acids
1
2019
71
0.150
 Why?
Quality Control
2
2015
171
0.140
 Why?
Organic Anion Transport Protein 1
2
2008
6
0.140
 Why?
Oxazines
1
2018
30
0.140
 Why?
Multidrug Resistance-Associated Proteins
2
2008
38
0.140
 Why?
Directly Observed Therapy
1
2017
15
0.140
 Why?
Bronchoalveolar Lavage Fluid
1
2020
655
0.140
 Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
2017
19
0.140
 Why?
Nitriles
2
2021
172
0.140
 Why?
Pregnancy Outcome
1
2020
412
0.130
 Why?
Pharmacogenetics
2
2016
179
0.130
 Why?
Inosine Triphosphate
1
2016
2
0.130
 Why?
Liver Cirrhosis
1
2019
316
0.130
 Why?
Anemia, Hemolytic
1
2016
20
0.130
 Why?
Darunavir
2
2014
19
0.130
 Why?
Deoxyadenine Nucleotides
1
2016
14
0.130
 Why?
Deoxycytosine Nucleotides
1
2016
11
0.130
 Why?
Glass
1
2016
45
0.130
 Why?
Drug Combinations
3
2025
343
0.130
 Why?
Guanosine Triphosphate
1
2016
91
0.130
 Why?
Pharmacy
1
2017
32
0.130
 Why?
Molecular Targeted Therapy
1
2019
411
0.130
 Why?
Genitalia
1
2016
30
0.130
 Why?
Disease Transmission, Infectious
1
2017
62
0.130
 Why?
Syringes
1
2016
43
0.130
 Why?
Drug Packaging
1
2016
45
0.130
 Why?
Drug and Narcotic Control
1
2016
28
0.130
 Why?
Viremia
3
2022
138
0.130
 Why?
Pyridones
1
2018
168
0.130
 Why?
Zika Virus
1
2017
128
0.120
 Why?
Fibroblast Growth Factors
2
2014
171
0.120
 Why?
Polymers
1
2019
488
0.120
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2011
443
0.120
 Why?
Biological Assay
1
2016
123
0.120
 Why?
Piperazines
1
2018
350
0.120
 Why?
Cytosol
1
2016
226
0.120
 Why?
Practice Guidelines as Topic
2
2016
1572
0.120
 Why?
Polymorphism, Single Nucleotide
2
2016
2184
0.120
 Why?
Creatinine
2
2018
499
0.120
 Why?
Retrospective Studies
4
2020
15510
0.120
 Why?
Brain Diseases
1
2016
141
0.120
 Why?
Population
1
2015
35
0.120
 Why?
Rectum
1
2016
185
0.120
 Why?
Analgesics
1
2017
206
0.120
 Why?
Nonlinear Dynamics
1
2015
88
0.120
 Why?
Chemical and Drug Induced Liver Injury
1
2016
136
0.110
 Why?
Mental Health Services
1
2019
416
0.110
 Why?
Liver Function Tests
1
2015
114
0.110
 Why?
CD4 Lymphocyte Count
2
2015
269
0.110
 Why?
Virus Replication
1
2017
482
0.110
 Why?
Pharmacists
1
2017
261
0.110
 Why?
Pharmaceutical Preparations
1
2016
179
0.110
 Why?
Adenosine Triphosphate
1
2016
487
0.110
 Why?
Least-Squares Analysis
1
2014
79
0.110
 Why?
Administration, Oral
3
2019
813
0.110
 Why?
Infectious Disease Transmission, Vertical
3
2025
182
0.110
 Why?
Metabolic Clearance Rate
2
2018
115
0.110
 Why?
Infant
5
2020
9395
0.110
 Why?
Cholecalciferol
1
2014
60
0.110
 Why?
Hypophosphatemia
1
2013
17
0.110
 Why?
Double-Blind Method
3
2013
1982
0.100
 Why?
Diphosphates
3
2021
17
0.100
 Why?
Calcitriol
1
2013
58
0.100
 Why?
Liver Diseases
1
2016
311
0.100
 Why?
Tablets
2
2023
40
0.100
 Why?
Cytochrome P-450 CYP3A
1
2013
88
0.100
 Why?
Leukocytes
1
2014
311
0.100
 Why?
Desiccation
1
2012
19
0.100
 Why?
Monocytes
1
2015
563
0.100
 Why?
Case-Control Studies
3
2024
3540
0.100
 Why?
Kidney Diseases
1
2016
407
0.090
 Why?
Benzoxazines
1
2012
31
0.090
 Why?
Organic Anion Transporters
1
2011
12
0.090
 Why?
Diabetes Mellitus
1
2020
1033
0.090
 Why?
Levonorgestrel
1
2012
38
0.090
 Why?
Pravastatin
1
2011
41
0.090
 Why?
Arylamine N-Acetyltransferase
1
2011
6
0.090
 Why?
Benchmarking
2
2024
183
0.090
 Why?
Child, Preschool
4
2021
10997
0.090
 Why?
Nucleosides
1
2011
27
0.090
 Why?
Interferon-alpha
1
2012
198
0.090
 Why?
Vitamin D Deficiency
1
2013
186
0.090
 Why?
Specimen Handling
1
2012
181
0.090
 Why?
Mental Disorders
1
2019
1070
0.090
 Why?
Contraceptive Agents, Female
1
2012
80
0.090
 Why?
Raltegravir Potassium
1
2010
17
0.090
 Why?
Models, Statistical
1
2015
668
0.090
 Why?
Hospitals, University
1
2011
182
0.080
 Why?
Body Weight
1
2015
985
0.080
 Why?
Patient Acceptance of Health Care
1
2017
805
0.080
 Why?
Sex Distribution
1
2011
374
0.080
 Why?
Cohort Studies
2
2019
5704
0.080
 Why?
Sex Characteristics
1
2015
763
0.080
 Why?
Dietary Supplements
1
2014
559
0.080
 Why?
Aged
5
2018
23808
0.080
 Why?
Mycobacterium tuberculosis
1
2012
312
0.080
 Why?
Time Factors
4
2016
6809
0.070
 Why?
Lamivudine
2
2023
63
0.070
 Why?
Rosuvastatin Calcium
1
2008
22
0.070
 Why?
Pregnancy
4
2025
6729
0.070
 Why?
Immunosuppressive Agents
1
2012
889
0.070
 Why?
Kidney Calculi
1
2007
37
0.070
 Why?
Portugal
1
2006
10
0.070
 Why?
Gene Frequency
1
2008
520
0.060
 Why?
Quebec
1
2006
11
0.060
 Why?
Furans
1
2006
24
0.060
 Why?
Education, Medical
1
2009
260
0.060
 Why?
Self Report
2
2021
822
0.060
 Why?
Dementia
1
2009
256
0.060
 Why?
Benzopyrans
1
2025
26
0.060
 Why?
Referral and Consultation
1
2011
780
0.060
 Why?
Internationality
1
2006
154
0.060
 Why?
Sexual and Gender Minorities
2
2019
213
0.060
 Why?
Hematocrit
2
2016
96
0.060
 Why?
United States
4
2017
14691
0.060
 Why?
Child
4
2021
21819
0.060
 Why?
Predictive Value of Tests
2
2019
2022
0.050
 Why?
Lipids
1
2008
665
0.050
 Why?
Isoindoles
1
2022
4
0.050
 Why?
Monkeypox virus
1
2022
17
0.050
 Why?
Risk Assessment
1
2012
3434
0.050
 Why?
Calibration
2
2013
146
0.050
 Why?
Demography
1
2022
291
0.050
 Why?
Treatment Failure
1
2023
354
0.050
 Why?
Computer Simulation
2
2016
973
0.050
 Why?
Benzamides
1
2022
216
0.050
 Why?
Temperature
2
2016
675
0.050
 Why?
Animals
4
2022
36850
0.050
 Why?
Drug Approval
1
2020
87
0.040
 Why?
Tissue Donors
1
2023
417
0.040
 Why?
Lactation
1
2020
181
0.040
 Why?
Dose-Response Relationship, Drug
2
2016
2052
0.040
 Why?
Models, Biological
2
2016
1773
0.040
 Why?
Developing Countries
1
2020
306
0.040
 Why?
Chemistry Techniques, Analytical
1
2018
21
0.040
 Why?
Flaviviridae
1
2017
6
0.030
 Why?
Vero Cells
1
2017
68
0.030
 Why?
Inhibitory Concentration 50
1
2017
90
0.030
 Why?
A549 Cells
1
2017
66
0.030
 Why?
Drug Repositioning
1
2017
35
0.030
 Why?
Hair
1
2018
84
0.030
 Why?
Pharmaceutical Solutions
1
2016
14
0.030
 Why?
Chromatography, Reverse-Phase
1
2016
28
0.030
 Why?
Breast Feeding
1
2020
439
0.030
 Why?
Patient Selection
1
2020
691
0.030
 Why?
Drug Storage
1
2016
57
0.030
 Why?
Defective Viruses
1
2016
5
0.030
 Why?
Cities
1
2017
132
0.030
 Why?
Acute Disease
1
2019
1007
0.030
 Why?
Drug Compounding
1
2016
101
0.030
 Why?
Solubility
1
2016
245
0.030
 Why?
Alcohol Drinking
1
2023
820
0.030
 Why?
Methanol
1
2016
38
0.030
 Why?
Spermatozoa
1
2016
94
0.030
 Why?
Clinical Trials as Topic
1
2020
1044
0.030
 Why?
Solutions
1
2016
167
0.030
 Why?
Cold Temperature
1
2016
178
0.030
 Why?
Hydrogen-Ion Concentration
1
2016
560
0.030
 Why?
Blood-Brain Barrier
1
2016
138
0.030
 Why?
Administration, Inhalation
1
2016
683
0.030
 Why?
Pregnancy Complications
1
2020
525
0.030
 Why?
Risk-Taking
1
2017
347
0.030
 Why?
Comorbidity
1
2019
1614
0.030
 Why?
Logistic Models
1
2020
2067
0.030
 Why?
Interleukins
1
2016
251
0.030
 Why?
DNA, Viral
1
2016
363
0.030
 Why?
Vitamin D-Binding Protein
1
2013
15
0.030
 Why?
Recurrence
1
2017
1055
0.030
 Why?
Feasibility Studies
1
2017
951
0.030
 Why?
Mental Health
1
2019
716
0.030
 Why?
Parathyroid Hormone
1
2013
108
0.020
 Why?
Algorithms
1
2020
1690
0.020
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
250
0.020
 Why?
Water
1
2016
457
0.020
 Why?
Therapeutic Equivalency
1
2012
32
0.020
 Why?
Alkynes
1
2012
56
0.020
 Why?
Cell Line
1
2017
2838
0.020
 Why?
Anion Exchange Resins
1
2011
8
0.020
 Why?
Zidovudine
1
2011
78
0.020
 Why?
Food-Drug Interactions
1
2010
9
0.020
 Why?
Reference Standards
1
2011
186
0.020
 Why?
Longitudinal Studies
1
2018
2829
0.020
 Why?
Chemoprevention
1
2010
92
0.020
 Why?
Latent Tuberculosis
1
2011
69
0.020
 Why?
Epithelial Cells
1
2016
1094
0.020
 Why?
Haplotypes
1
2011
494
0.020
 Why?
Cholesterol
1
2011
410
0.020
 Why?
Glomerular Filtration Rate
1
2013
745
0.020
 Why?
Triglycerides
1
2011
524
0.020
 Why?
AIDS Dementia Complex
1
2009
51
0.020
 Why?
Infant, Newborn
1
2020
6032
0.020
 Why?
Polymorphism, Genetic
1
2011
659
0.020
 Why?
Follow-Up Studies
1
2017
5106
0.020
 Why?
Cross-Sectional Studies
1
2019
5424
0.020
 Why?
Acquired Immunodeficiency Syndrome
1
2009
232
0.020
 Why?
Positron-Emission Tomography
1
2009
293
0.020
 Why?
Antiemetics
1
1987
43
0.020
 Why?
Calcium
1
2013
1197
0.020
 Why?
Vomiting
1
1987
130
0.020
 Why?
Gene Expression Regulation
1
2016
2605
0.020
 Why?
Aged, 80 and over
1
2018
7593
0.020
 Why?
Neuropsychological Tests
1
2009
1022
0.010
 Why?
Brain
1
2016
2664
0.010
 Why?
Age Factors
1
2011
3286
0.010
 Why?
Alzheimer Disease
1
2009
559
0.010
 Why?
Magnetic Resonance Imaging
1
2009
3556
0.010
 Why?
Antineoplastic Agents
1
1987
2123
0.010
 Why?
Flunitrazepam
1
1987
3
0.000
 Why?
Metoclopramide
1
1987
19
0.000
 Why?
Methylprednisolone
1
1987
85
0.000
 Why?
Kiser's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (358) concept(s)
_
Co-Authors Expand Description
See all (31) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)